CryptoNewsBreaks – Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) Subsidiary MindWave Signs 12-Month Technology Services Agreement with AQUAE Holdings
Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) subsidiary MindWave Innovations Inc. signed a 12-month technology services agreement with Singapore-based AQUAE Holdings Pte. Ltd. to deploy its MindChain infrastructure as the foundation of AQUAEChain, a platform for insured ALCI Credits. MindWave will design, develop, deploy and host AQUAEChain, which will manage the issuance, verification, tracking, transfer and retirement of ALCI Credits, and will provide ongoing technical support. MindWave will receive contracted software development and technology service fees, while the agreement also references an allocation to MindWave equal to 20% of total ALCI Credits issued and outstanding on the AQUAEChain network, calculated…





